Modification of class III anti-arrhythmic activity in abnormal myocardium.
Cobbe
S M
SM
Department of Medical Cardiology, Royal Infirmary, Glasgow, Scotland.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D003327:Coronary Disease / Q000503:physiopathology*; D006321:Heart / Q000187:drug effects*; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans
D000889:Anti-Arrhythmia Agents